Cypress Capital Group boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,174 shares of the healthcare product maker’s stock after buying an additional 698 shares [...]
Abbott Laboratories (NYSE:ABT) Shares Purchased by Cypress Capital Group
